Regeneron Pharmaceuticals Inc - Company & Market Research Reports

Home /
Companies /
Regeneron Pharmaceuticals Inc

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 81
Optical 75
Immune Disorders Drugs 73
Optical Disorders Drugs 68
Drug Discovery 54
Cardiovascular Drugs 46
Biopharmaceuticals 37
Dermatological Drugs 37
Musculoskeletal Disorders Drugs 37
Biotechnology 33
Genomics 28
Clinical Trials 22
Central Nervous System Drugs 19
Pharmaceuticals 19
Skin Cancer Drugs 19
Endocrine and Metabolic Disorders Drugs 19
Infectious Diseases Drugs 18
Allergy and Immunology 17
Drugs by Therapeutic Area 16
Respiratory Drugs 15
Infusions and Injectables 14
Allergy Drugs 13
Lung Cancer Drugs 12
Gastrointestinal Drugs 11
Dermatology 10
Oncology 10
Hematological Drugs 9
Leukemia Drugs 8
Needles and Syringes 8
Diagnostics 7
Biosimilars and Biosuperiors 7
Pharmaceutical Manufacturing 7
Prostate Cancer Drugs 6
Enzymes 6
Vaccines 6
Asthma Drugs 6
Therapeutic Area 5
Drug Delivery 5
Liver and Kidney Disorders Drugs 5
Gastroenterology 5
Company Reports 4
Pulmonary Medicine 4
Lymphoma Drugs 4
Ovarian Cancer Drugs 4
Proteomics 4
Transdermal and Transmucosal Drug Delivery 4
Pharmaceutical Intermediates 3
Diabetes Drugs 3
Colon Cancer Drugs 3
Cardiovascular Devices 3
Medical Devices 3
Pediatrics 3
Endocrinology 3
Sexual and Reproductive Health Drugs 3
Immunosuppressive Drugs 3
Liver Cancer Drugs 2
Healthcare Services 2
Cervical Cancer Drugs 2
Brain Cancer Drugs 2
Analgesics 2
Cough and Cold Drugs 2
Mental Disorders Drugs 2
Kidney Cancer Drugs 2
Thyroid Cancer Drugs 2
Laboratory Equipment 2
Anti-Obesity Drugs 2
Cardiology 2
Neurology 1
Hepatology 1
Generic Drugs 1
Pharmacoeconomics 1
Fertility Services 1
Bladder Cancer Drugs 1
In Vitro Diagnostics 1
Infectious Disease Testing 1
Cholesterol Testing 1
Laboratory Testing 1
Inhalers and Nebulisers 1
Stem Cells 1
Blood Banking 1
Anesthetic Drugs 1
Biomarkers 1
Hematology 1
Nursing 1
Surgical Devices 1
Over the Counter (OTC) Drugs 1
Endoscopy 1
Pancreatic Cancer Drugs 1
Uterine Cancer Drugs 1
Nanomedicine 1
Alzheimer's Disease Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

682 Results (Page 6 of 35)
- Relevance
  Sort by

Non-Small Cell Lung Cancer (NSCLC) Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3997EUR$4,490USD£3,493GBP

Fusion Protein VEGF Inhibitor Market - Global Forecast 2025-2030

 Report
August 2025
186 Pages
Global

From

€3156EUR$3,545USD£2,758GBP

€3507EUR$3,939USD£3,064GBP

Skin Cancer Treatment Market Analysis & Forecast 2024-2034: Market By Indication; By Therapy; By Distribution Channel; and By Region

 Report
October 2023
145 Pages
Global

From

€2804EUR$3,150USD£2,450GBP

Global CD3 Antibodies Market, Dosage, Price, Sales & Clinical Trials Insight 2028

 Report
October 2023
470 Pages
Global

From

€1994EUR$2,240USD£1,742GBP

€2493EUR$2,800USD£2,178GBP

Allergy Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3997EUR$4,490USD£3,493GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Myasthenia Gravis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032

 Report
October 2023
68 Pages
Global

From

€8898EUR$9,995USD£7,775GBP

Atopic Dermatitis Drugs - Global Strategic Business Report

 Report
October 2025
179 Pages
Global

From

€5208EUR$5,850USD£4,550GBP

Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields, Plungers, Stoppers, Seals, Tip Caps and Other Closures

 Report
May 2019
385 Pages
Global

From

€4005EUR$4,499USD£3,500GBP

RNAi Drug Delivery - Global Strategic Business Report

 Report
October 2025
294 Pages
Global

From

€5208EUR$5,850USD£4,550GBP

Atopic Dermatitis Drugs Market Size, Share & Trends Analysis Report By Drug Class, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

 Report
December 2024
120 Pages
Global

From

€5297EUR$5,950USD£4,628GBP

Rheumatoid Arthritis Therapeutics - Global Strategic Business Report

 Report
October 2025
150 Pages
Global

From

€5208EUR$5,850USD£4,550GBP

Constipation Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3997EUR$4,490USD£3,493GBP

Acute Pancreatitis Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3997EUR$4,490USD£3,493GBP

Autoinjectors: Intellectual Property Landscape, Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions, Patent Valuation Analysis, Patentability, Freedom to Operate, Pockets of Innovation, Existing White Spaces, and Claims Analysis

 Report
January 2023
205 Pages
Global

From

€1691EUR$1,899USD£1,477GBP

Adenoid Cystic Carcinoma - Global Strategic Business Report

 Report
October 2025
386 Pages
Global

From

€5208EUR$5,850USD£4,550GBP

Programmed death-ligand 1 (PD-L1) Non-small Cell Lung Cancer (NSCLC) - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€5662EUR$6,360USD£4,947GBP

€7077EUR$7,950USD£6,184GBP

Edema Clinical Trials - Global Strategic Business Report

 Report
October 2025
461 Pages
Global

From

€5208EUR$5,850USD£4,550GBP

Nasal Allergy Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
June 2025
260 Pages
Global

From

€4447EUR$4,995USD£3,885GBP

Erdheim Chester Disease Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3997EUR$4,490USD£3,493GBP

Metastatic Non-Small Cell Lung Cancer - Market Insight, Epidemiology and Market Forecast -2032

 Report
November 2023
630 Pages
Global

From

€6766EUR$7,600USD£5,912GBP

€8457EUR$9,500USD£7,390GBP

682 Results (Page 6 of 35)
- 1
- 4
- 5
- 6
- 7
- 8

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.